ClinicalTrials.govpublic full text
HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
melanoma, skin neoplasms, advanced melanoma, braf v600 mutation, vorinostat, hdac inhibitor, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1047585
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.